Merck KGaA (ETR:MRK - Get Free Report) shares dropped 0.7% on Friday . The company traded as low as €118.90 ($135.11) and last traded at €119.75 ($136.08). Approximately 276,859 shares traded hands during mid-day trading, The stock had previously closed at €120.60 ($137.05).
Merck KGaA Price Performance
The company's 50-day simple moving average is €127.06 and its 200-day simple moving average is €138.66. The stock has a market capitalization of $54.31 billion, a price-to-earnings ratio of 20.03, a P/E/G ratio of 2.37 and a beta of 0.71.
Merck KGaA Company Profile
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Recommended Stories
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
